• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性高胆固醇血症大鼠肝脏中β-氧化和生脂基因表达的益生元和合生元修饰

Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver.

作者信息

Alves Claudia C, Waitzberg Dan L, de Andrade Laila S, Dos Santos Aguiar Laís, Reis Milene B, Guanabara Camila C, Júnior Odair A, Ribeiro Daniel A, Sala Priscila

机构信息

Department of Biosciences, Federal University of São Paulo, Santos, Brazil.

Department of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.

出版信息

Front Microbiol. 2017 Oct 17;8:2010. doi: 10.3389/fmicb.2017.02010. eCollection 2017.

DOI:10.3389/fmicb.2017.02010
PMID:29089934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5650986/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by the presence of fat in hepatocytes because of decreased β-oxidation and increased lipogenesis. Prebiotics, probiotics, and synbiotic have modulatory effects on intestinal microbiota and may influence the gut-liver axis. Our aim was to evaluate the effects of prebiotic, probiotics, and synbiotic on liver histopathology and gene expression related to β-oxidation and lipogenesis after hypercholesterolemia. Wistar male adult rats ( = 40) were submitted to hypercholesterolemic conditions (HPC) (60 days). On Day 30 of HPC, rats were subdivided in 5 groups: negative control (NC): without HPC + Gv (distilled water); positive control (PC): with HPC + Gv (distilled water); prebiotic (PRE): HPC + Gv with prebiotic (Fiber FOS); probiotic (PRO): HPC + Gv with probiotic strains Gv (Probiatop); and synbiotic (SYN): HPC + Gv with synbiotic (Simbioflora). All rats were sacrificed on Day 30 post-treatment. Blood was collected to verify total serum cholesterol, and liver tissue was sampled to verify histopathological changes and gene expression. Gene expression related to ß-oxidation (PPAR-α and CPT-1) and lipogenesis (SREBP-1c, FAS and ME) was evaluated in liver tissue using RT-qPCR. PC had higher cholesterol levels when compared to NC. PRE and SYN rats had lower cholesterol levels than PC. PC rats showed more histopathological changes than NC rats; PRE and SYN rats showed fewer alterations than PC rats. was expressed at higher levels in SYN and PC rats compared with PRE and PRO rats. expression was similar in all groups. was expressed at higher levels in PC rats compared with NC rats; levels were lower in SYN rats compared with PRO rats; levels were lower in PRE rats compared with PC and PRO rats. was expressed at lower levels in PRE rats compared with SYN rats. expression was lower in PC rats compared with NC rats. Prebiotic and synbiotic supplementation improve hepatic alterations related to hypercholesterolemia. These changes appear to be mediated by altered expression of genes related to β-oxidation and lipogenesis.

摘要

非酒精性脂肪性肝病(NAFLD)的特征是由于β-氧化减少和脂肪生成增加,肝细胞中存在脂肪。益生元、益生菌和合生元对肠道微生物群具有调节作用,并可能影响肠-肝轴。我们的目的是评估益生元、益生菌和合生元对高胆固醇血症后肝脏组织病理学以及与β-氧化和脂肪生成相关的基因表达的影响。将40只成年雄性Wistar大鼠置于高胆固醇血症条件(HPC)下60天。在HPC第30天,将大鼠分为5组:阴性对照(NC):未进行HPC + 给予Gv(蒸馏水);阳性对照(PC):进行HPC + 给予Gv(蒸馏水);益生元组(PRE):HPC + 给予含有益生元(低聚果糖)的Gv;益生菌组(PRO):HPC + 给予含有益生菌菌株Gv(Probiatop)的Gv;合生元组(SYN):HPC + 给予含有合生元(Simbioflora)的Gv。所有大鼠在治疗后第30天处死。采集血液以检测总血清胆固醇,并采集肝脏组织样本以检测组织病理学变化和基因表达。使用逆转录定量聚合酶链反应(RT-qPCR)评估肝脏组织中与β-氧化(PPAR-α和CPT-1)和脂肪生成(SREBP-1c、FAS和ME)相关的基因表达。与NC相比,PC组胆固醇水平更高。PRE组和SYN组大鼠的胆固醇水平低于PC组。PC组大鼠比NC组大鼠表现出更多的组织病理学变化;PRE组和SYN组大鼠比PC组大鼠表现出的变化更少。与PRE组和PRO组大鼠相比,SYN组和PC组大鼠中[未提及具体基因名称]表达水平更高。[未提及具体基因名称]在所有组中的表达相似。与NC组大鼠相比,PC组大鼠中[未提及具体基因名称]表达水平更高;与PRO组大鼠相比,SYN组大鼠中[未提及具体基因名称]水平更低;与PC组和PRO组大鼠相比,PRE组大鼠中[未提及具体基因名称]水平更低。与SYN组大鼠相比,PRE组大鼠中[未提及具体基因名称]表达水平更低。与NC组大鼠相比,PC组大鼠中[未提及具体基因名称]表达更低。补充益生元和合生元可改善与高胆固醇血症相关的肝脏改变。这些变化似乎是由与β-氧化和脂肪生成相关基因的表达改变介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8233/5650986/248595ce74c9/fmicb-08-02010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8233/5650986/39c1fd2b11b9/fmicb-08-02010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8233/5650986/248595ce74c9/fmicb-08-02010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8233/5650986/39c1fd2b11b9/fmicb-08-02010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8233/5650986/248595ce74c9/fmicb-08-02010-g002.jpg

相似文献

1
Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver.实验性高胆固醇血症大鼠肝脏中β-氧化和生脂基因表达的益生元和合生元修饰
Front Microbiol. 2017 Oct 17;8:2010. doi: 10.3389/fmicb.2017.02010. eCollection 2017.
2
Performance, biochemical and haematological responses, and relative organ weights of laying hens fed diets supplemented with prebiotic, probiotic and synbiotic.饲喂添加益生元、益生菌和合生元日粮的蛋鸡的生产性能、生化和血液学反应以及相对器官重量
BMC Vet Res. 2017 Aug 17;13(1):248. doi: 10.1186/s12917-017-1160-y.
3
Chemical Compositions of Egg Yolks and Egg Quality of Laying Hens Fed Prebiotic, Probiotic, and Synbiotic Diets.饲喂益生元、益生菌和合生元日粮的蛋鸡蛋黄化学成分及蛋品质
J Food Sci. 2015 Aug;80(8):C1686-95. doi: 10.1111/1750-3841.12947. Epub 2015 Jul 14.
4
Effect of dietary probiotic, prebiotic and synbiotic supplementation on performance, immune responses, intestinal morphology and bacterial populations in broilers.日粮添加益生菌、益生元及合生元对肉鸡生产性能、免疫反应、肠道形态和细菌菌群的影响。
J Anim Physiol Anim Nutr (Berl). 2016 Aug;100(4):694-700. doi: 10.1111/jpn.12431. Epub 2016 Feb 5.
5
Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model.益生菌-益生元-合生菌对 NASH 动物模型中(YAP1、LATS1 和 NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1)的调控。
Biomed Pharmacother. 2021 Aug;140:111781. doi: 10.1016/j.biopha.2021.111781. Epub 2021 Jun 2.
6
Cupuassu (Theobroma grandiflorum) pulp, probiotic, and prebiotic: Influence on color, apparent viscosity, and texture of goat milk yogurts.库阿苏(大花可可树)果肉、益生菌和益生元:对山羊奶酸奶颜色、表观粘度和质地的影响。
J Dairy Sci. 2015 Sep;98(9):5995-6003. doi: 10.3168/jds.2015-9738. Epub 2015 Jul 15.
7
Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.反式查耳酮对非酒精性脂肪性肝炎的预防作用:改善肝脏脂质代谢。
Biomed Pharmacother. 2019 Jan;109:1306-1312. doi: 10.1016/j.biopha.2018.10.196. Epub 2018 Nov 9.
8
Synbiotic dietary supplement affects growth, immune responses and intestinal microbiota of Apostichopus japonicus.合生元膳食补充剂影响刺参的生长、免疫反应和肠道微生物群。
Fish Shellfish Immunol. 2017 Sep;68:232-242. doi: 10.1016/j.fsi.2017.07.027. Epub 2017 Jul 11.
9
Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.肥胖患者肝脏中SREBP-1c/PPAR-α比值升高及脂肪变性:与胰岛素抵抗和n-3长链多不饱和脂肪酸缺乏的相关性
Biochim Biophys Acta. 2009 Nov;1792(11):1080-6. doi: 10.1016/j.bbadis.2009.08.015. Epub 2009 Sep 4.
10
Application of Probiotic, Prebiotic and Synbiotic for the Control of Streptococcosis in Tilapia Oreochromis niloticus.益生菌、益生元及合生元在罗非鱼无乳链球菌病防治中的应用
Pak J Biol Sci. 2015 Feb;18(2):59-66. doi: 10.3923/pjbs.2015.59.66.

引用本文的文献

1
Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value.代谢功能障碍相关脂肪性肝病中的肠道微生物群与代谢组学:相互作用、机制及治疗价值
Front Cell Infect Microbiol. 2025 Jul 23;15:1635638. doi: 10.3389/fcimb.2025.1635638. eCollection 2025.
2
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群:病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
3
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis.

本文引用的文献

1
Adipose tissue, obesity and non-alcoholic fatty liver disease.脂肪组织、肥胖与非酒精性脂肪性肝病
Minerva Endocrinol. 2017 Jun;42(2):92-108. doi: 10.23736/S0391-1977.16.02563-3. Epub 2016 Oct 6.
2
The role of the gut microbiota in NAFLD.肠道微生物群在非酒精性脂肪性肝病中的作用。
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25. doi: 10.1038/nrgastro.2016.85. Epub 2016 Jun 8.
3
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet.饮食、微生物群、肥胖与非酒精性脂肪性肝病:一个危险的四重奏。
肠道微生物群靶向治疗在非酒精性脂肪性肝病中的作用:一项系统评价和网状Meta分析
Front Nutr. 2025 Jan 6;11:1470185. doi: 10.3389/fnut.2024.1470185. eCollection 2024.
4
Probiotics-role in alleviating the impact of alcohol liver disease and alcohol deaddiction: a systematic review.益生菌在减轻酒精性肝病影响及戒酒方面的作用:一项系统评价
Front Nutr. 2024 Aug 30;11:1372755. doi: 10.3389/fnut.2024.1372755. eCollection 2024.
5
Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model.基于机器学习的非酒精性脂肪性肝炎动物模型药物疗效预测潜在特征基因鉴定。
Lipids Health Dis. 2024 Aug 24;23(1):266. doi: 10.1186/s12944-024-02231-9.
6
alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA.通过3 - HPAA下调组蛋白乙酰化水平,减轻饮食诱导的代谢功能障碍相关脂肪性肝病的进展。
Gut Microbes. 2024 Jan-Dec;16(1):2309683. doi: 10.1080/19490976.2024.2309683. Epub 2024 Feb 5.
7
Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice.运动训练和绿原酸补充对糖尿病前期小鼠肝脂代谢的影响。
Diabetes Metab J. 2023 Nov;47(6):771-783. doi: 10.4093/dmj.2022.0265. Epub 2023 Sep 8.
8
The Symbiosis Between Lactobacillus acidophilus and Inulin: Metabolic Benefits in an Obese Murine Model.嗜酸乳杆菌与菊粉的共生关系:肥胖小鼠模型中的代谢益处。
Probiotics Antimicrob Proteins. 2024 Feb;16(1):26-34. doi: 10.1007/s12602-022-10012-y. Epub 2022 Nov 29.
9
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role.非酒精性脂肪性肝病中的肠道微生物群:从机制到治疗作用
Biomedicines. 2022 Feb 25;10(3):550. doi: 10.3390/biomedicines10030550.
10
Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review.益生菌和益生元作为非酒精性脂肪性肝病的一种治疗策略:一篇叙述性综述
Foods. 2021 Jul 25;10(8):1719. doi: 10.3390/foods10081719.
Int J Mol Sci. 2016 Apr 1;17(4):481. doi: 10.3390/ijms17040481.
4
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的多重打击发病机制。
Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012. Epub 2016 Jan 4.
5
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
6
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.非酒精性脂肪性肝病的流行病学影响因素:聚焦高危人群。
Dig Liver Dis. 2015 Dec;47(12):997-1006. doi: 10.1016/j.dld.2015.08.004. Epub 2015 Aug 14.
7
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.肠-肝轴、营养与非酒精性脂肪性肝病。
Clin Biochem. 2015 Sep;48(13-14):923-30. doi: 10.1016/j.clinbiochem.2015.06.023. Epub 2015 Jul 4.
8
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.肝硬化中的肠-肝轴:如何应对肠道渗漏和内毒素血症。
World J Hepatol. 2015 Mar 27;7(3):425-42. doi: 10.4254/wjh.v7.i3.425.
9
Gut microbiota and liver diseases.肠道微生物群与肝脏疾病
World J Gastroenterol. 2015 Feb 14;21(6):1691-702. doi: 10.3748/wjg.v21.i6.1691.
10
Hepatic inflammation and fibrosis: functional links and key pathways.肝脏炎症与纤维化:功能联系及关键通路
Hepatology. 2015 Mar;61(3):1066-79. doi: 10.1002/hep.27332. Epub 2015 Jan 28.